- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07451834
Stressball-intervensjon under aktiv fødsel
Stress Ball Use as a Tactile Coping Intervention During Active Labour: Effects on Maternal Self-Efficacy in a Randomized Controlled Trial
This randomized controlled trial evaluates the effect of a stress ball intervention used during the active phase of labor primarily on maternal self-efficacy, while secondarily examining childbirth comfort, labor pain intensity, and labor progress. Labor pain is a multidimensional experience influenced by physiological and psychological factors, including coping and perceived control. Simple non-pharmacological interventions may support women's coping and active participation during labor.
Participants in the intervention group use a stress ball during uterine contractions throughout the active phase of labor in addition to routine midwifery care, while participants in the control group receive routine midwifery care alone. Maternal self-efficacy and childbirth comfort are assessed at baseline during the active phase of labor and within 24 hours postpartum. Labor pain intensity is assessed using a Visual Analogue Scale at predefined cervical dilatation levels (5, 6, 8, and 10 cm). Labor progress parameters, including uterine contraction characteristics and fetal heart rate, are also monitored throughout the active phase.
The primary objective is to determine whether stress ball use during active labor improves maternal self-efficacy. Secondary objectives are to evaluate its effects on childbirth comfort and labor pain intensity and to examine whether the intervention adversely affects physiological labor progress.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
This study is a single-center, parallel-group randomized controlled trial designed to evaluate the effects of a stress ball intervention during the active phase of labor. The intervention is based on theoretical concepts of distraction, active coping, perceived control, and self-efficacy. The primary objective is to determine whether stress ball use during active labor improves maternal self-efficacy. Secondary objectives are to evaluate its effects on childbirth comfort and labor pain intensity and to examine whether the intervention adversely affects physiological labor progress.
Eligible participants are low-risk pregnant women with singleton pregnancies at 37-42 weeks of gestation who are in the active phase of spontaneous labor (cervical dilatation ≥5 cm). Following baseline assessment, participants are randomized in a 1:1 ratio to either the intervention group or the control group. The intervention group receives routine midwifery care plus stress ball use during uterine contractions throughout the active phase of labor, whereas the control group receives routine midwifery care alone.
Maternal self-efficacy, the primary outcome, is assessed at baseline during the active phase of labor and within 24 hours postpartum. Childbirth comfort is assessed at the same time points as a secondary outcome. Labor pain intensity is assessed using a 100-mm Visual Analogue Scale at cervical dilatation levels of 5, 6, 8, and 10 cm. Labor progress parameters, including cervical dilatation, uterine contraction characteristics, and fetal heart rate, are monitored throughout the active phase of labor to evaluate physiological labor progression and safety.
For the primary outcome, between-group differences in post-intervention maternal self-efficacy are evaluated while accounting for baseline self-efficacy. Childbirth comfort is evaluated similarly as a secondary outcome. Repeated measurements of labor pain across cervical dilatation levels are analyzed to examine group differences, changes across labor progression, and the group-by-dilatation interaction.
The study is designed to determine whether stress ball use during active labor can support maternal self-efficacy and coping while evaluating its effects on childbirth comfort and pain intensity and ensuring that the intervention does not adversely affect physiological labor progression.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Konya
-
Karatay, Konya, Tyrkia (Türkiye)
- KTO Karatay University
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Aged 18-35 years,
- Singleton pregnancy at 37-42 weeks of gestation,
- In the active phase of spontaneous labor with cervical dilatation ≥5 cm,
- No mental or physical disability that would prevent participation in the study,
- Able to speak and understand Turkish,
- Provided voluntary informed consent to participate in the study.
Exclusion Criteria:
- High-risk pregnancy,
- Presence of a systemic disease or medical or obstetric complication,
- Use of epidural analgesia or other pharmacological pain management during labor.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Stress Ball + Routine Midwifery Care
Participants receive routine midwifery care plus stress ball use throughout the active phase of labor. Participants are instructed to rhythmically squeeze the stress ball during uterine contractions and release it during the relaxation periods between contractions. Stress ball use is continued throughout the active phase of labor in addition to routine midwifery care. |
A handheld stress ball used during uterine contractions throughout the active phase of labor to support coping through distraction and enhance perceived control. |
|
Ingen inngripen: Routine Midwifery Care (Control)
Participants receive routine midwifery care only, including standard labor monitoring and supportive care according to hospital protocol. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Maternal Self-Efficacy
Tidsramme: Baseline during the active phase of labor and within 24 hours postpartum.
|
Maternal self-efficacy is assessed using the 17-item Self-Efficacy Scale. Each item is rated on a 5-point Likert scale, yielding a total score ranging from 17 to 85. Higher total scores indicate higher perceived self-efficacy. |
Baseline during the active phase of labor and within 24 hours postpartum.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Childbirth Comfort
Tidsramme: Baseline (active phase onset) and within 24 hours postpartum.
|
Childbirth comfort is assessed using the 9-item Childbirth Comfort Scale. Each item is rated on a 5-point Likert scale, yielding a total score ranging from 9 to 45. Higher total scores indicate higher levels of childbirth comfort. |
Baseline (active phase onset) and within 24 hours postpartum.
|
|
Labor Pain Intensity
Tidsramme: At 5, 6, 8, and 10 cm cervical dilatation during the active phase of labor.
|
Labor pain intensity is assessed using a 100-mm Visual Analogue Scale (VAS), ranging from 0 mm ("no pain") to 100 mm ("worst imaginable pain"). Higher scores indicate greater perceived pain intensity. |
At 5, 6, 8, and 10 cm cervical dilatation during the active phase of labor.
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- KaratayU-RCT-StressBall-2025
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .